John West
Family Medicine · Pineville, WVNPI 1295826576
Payments from drug & device makers
Across 365 payments — averaging $15.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$783
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$782
- AstraZeneca$556
- GSK$530
- Merck$350
- AbbVie$347
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $783 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 60 | $782 |
| AstraZeneca | 31 | $556 |
| GSK | 36 | $530 |
| Merck | 23 | $350 |
| AbbVie | 26 | $347 |
| Boehringer Ingelheim | 15 | $227 |
| Abbott | 12 | $222 |
| Pfizer | 19 | $210 |
| Redhill Biopharma Inc. | 15 | $196 |
| Dexcom, Inc. | 8 | $187 |
| Novartis | 9 | $156 |
| Biohaven Pharmaceuticals, Inc. | 12 | $155 |
| Amgen | 9 | $120 |
| Sunovion Pharmaceuticals Inc. | 6 | $79 |
| Lilly USA, LLC | 5 | $76 |
| Verona Pharma, Inc. | 3 | $67 |
| Idorsia Pharmaceuticals US Inc | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Amarin Pharma, Inc. | 3 | $51 |
| Bayer | 2 | $42 |
| Adamas Pharmaceuticals, Inc. | 3 | $41 |
| Esperion Therapeutics, Inc. | 3 | $38 |
| Almatica Pharma LLC | 3 | $38 |
| Biogen | 2 | $29 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
| Avanir Pharmaceuticals, Inc. | 2 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Genentech USA, Inc. | 2 | $8 |
How this compares
$5,523 in reported general payments places this provider in the 90th percentile of 843 family medicine providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $75,261 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 100 | $71,045 |
| EliquisApixaban | 88 | $53,892 |
| FarxigaDapagliflozin Propanediol | 70 | $53,251 |
| JanuviaSitagliptin Phosphate | 79 | $50,736 |
| LinzessLinaclotide | 63 | $38,059 |
| TradjentaLinagliptin | 58 | $37,852 |
| EntrestoSacubitril/Valsartan | 54 | $37,420 |
| JardianceEmpagliflozin | 57 | $35,970 |
| Tresiba Flextouch U-200Insulin Degludec | 29 | $30,526 |
| RybelsusSemaglutide | 18 | $28,463 |
| MounjaroTirzepatide | 20 | $22,988 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 29 | $17,738 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $14,352 |
| SymbicortBudesonide/Formoterol Fumarate | 54 | $13,146 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $783 | $103,72398 claims |
| Boehringer IngelheimTradjenta, Jardiance, Spiriva Respimat, Combivent Respimat, Stiolto Respimat | $227 | $96,422160 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $556 | $91,058169 claims |
| GSKTrelegy Ellipta | $530 | $71,045100 claims |
| PfizerEliquis | $210 | $53,89288 claims |
| MerckJanuvia | $350 | $50,73679 claims |
| AbbVieLinzess | $347 | $38,05963 claims |
| NovartisEntresto | $156 | $37,42054 claims |
| Lilly USA, LLCMounjaro | $76 | $22,98820 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $782 | $8,90215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 843 family medicine providers in West Virginia.
Other family medicine in Pineville
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Julie DetempleSouth Charleston$129K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
- Mark CucuzzellaHarpers Ferry$59K
- Courtney PilkertonMorgantown$45K
- Isha WoofterClarksburg$27K
- Dominick WoofterClarksburg$27K
- Ryan RunyonPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.